OnKure Therapeutics, Inc. (OKUR)
3.89
-0.05
(-1.27%)
USD |
NASDAQ |
Aug 24, 16:00
3.86
-0.03
(-0.77%)
After-Hours: 20:00
OnKure Therapeutics Shareholders Equity (Quarterly) : 172.11M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 172.11M |
| March 31, 2026 | 184.35M |
| December 31, 2025 | 56.18M |
| September 30, 2025 | 66.43M |
| June 30, 2025 | 78.17M |
| March 31, 2025 | 90.65M |
| December 31, 2024 | 103.83M |
| September 30, 2024 | 74.02M |
| June 30, 2024 | 76.87M |
| March 31, 2024 | 81.24M |
| December 31, 2023 | 27.98M |
| September 30, 2023 | 114.94M |
| Date | Value |
|---|---|
| June 30, 2023 | 132.53M |
| March 31, 2023 | 87.08M |
| December 31, 2022 | 99.97M |
| September 30, 2022 | 112.04M |
| June 30, 2022 | 124.16M |
| March 31, 2022 | 135.32M |
| December 31, 2021 | 147.21M |
| September 30, 2021 | 156.21M |
| June 30, 2021 | 167.55M |
| March 31, 2021 | -48.72M |
| December 31, 2020 | -42.12M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Theriva Biologics, Inc. | 12.19M |
| Nkarta, Inc. | 247.74M |
| Unicycive Therapeutics, Inc. | 53.27M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 179.35M |
| Total Liabilities (Quarterly) | 7.245M |
| Debt to Equity Ratio | 0.0054 |
| Current Ratio | 26.75 |
| Net Debt Paydown Yield | 0.00% |